These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18495217)

  • 41. Detection of lupus anticoagulant: an evaluation of routines for preparation and storage of plasma.
    Schjetlein R; Wisløff F
    Thromb Res; 1995 Jul; 79(1):135-40. PubMed ID: 7495101
    [No Abstract]   [Full Text] [Related]  

  • 42. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.
    J Clin Pathol; 1991 Nov; 44(11):885-9. PubMed ID: 1752976
    [No Abstract]   [Full Text] [Related]  

  • 43. Dishomogeneous separation of citrated plasma in primary collection tubes for routine coagulation testing.
    Lippi G; Salvagno GL; Bassi A; Montagnana M; Poli G; Guidi GC
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):330-2. PubMed ID: 18469561
    [No Abstract]   [Full Text] [Related]  

  • 44. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?
    Devreese KM
    Thromb Res; 2008; 122(4):576-9. PubMed ID: 18304615
    [No Abstract]   [Full Text] [Related]  

  • 45. Prothrombin deficiency and hemorrhage associated with a lupus anticoagulant.
    Grau E; Real E; Pastor E; Ivorra J; Quecedo E
    Am J Hematol; 1997 Jan; 54(1):85. PubMed ID: 8980268
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinically appropriate investigations in cases of suspected lupus anticoagulant.
    Bridgen ML; Ferguson DJ
    Am J Clin Pathol; 1994 Aug; 102(2):266-8. PubMed ID: 8042599
    [No Abstract]   [Full Text] [Related]  

  • 47. Improved lupus anticoagulant assay.
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):122. PubMed ID: 1623114
    [No Abstract]   [Full Text] [Related]  

  • 48. The incidence and impact of lupus anticoagulants among patients in the intensive care unit.
    Aldawood AS; Crowther M; Jaeschke R; Dabbagh O; Alkhairy K; Baharoon S; Ahmed N
    Saudi Med J; 2005 Dec; 26(12):1994-5. PubMed ID: 16380791
    [No Abstract]   [Full Text] [Related]  

  • 49. Activated partial thromboplastin time: new tricks for an old dogma.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2008 Oct; 34(7):604-11. PubMed ID: 19085761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of low levels of lupus anticoagulant antibodies.
    Villa P; Mira Y; Ferrando F; Vayá A; Aznar J
    Thromb Res; 2005; 116(5):447-9. PubMed ID: 15925399
    [No Abstract]   [Full Text] [Related]  

  • 51. [On the presence of circulating anticoagulants in a case of systemic lupus erythematosus. Preliminary studies].
    Porro T; Sideri GC; Valentini R
    Haematol Lat; 1968; 11(1):31-7. PubMed ID: 5722007
    [No Abstract]   [Full Text] [Related]  

  • 52. A clinical study of the lupus anticoagulant.
    Schleider MA; Nachman RL; Jaffe EA; Coleman M
    Blood; 1976 Oct; 48(4):499-509. PubMed ID: 963290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged activated partial thromboplastin time in patients with antiphospholipid antibody syndrome.
    Dyer JR; Raj T
    Anesth Analg; 2006 Dec; 103(6):1586-7; author reply 1587-8. PubMed ID: 17122253
    [No Abstract]   [Full Text] [Related]  

  • 54. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Index of circulating anticoagulant cut-off value establishment in activated partial thromboplastin time mixing test for lupus anticoagulant diagnosis.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Aoki T
    J Thromb Haemost; 2013 Oct; 11(10):1919-22. PubMed ID: 23819748
    [No Abstract]   [Full Text] [Related]  

  • 56. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
    Staropoli JF; Van Cott EM; Makar RS
    Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Why is the patient losing proteins via the intestines?].
    Stiefelhagen P
    MMW Fortschr Med; 2006 Apr; 148(16):13. PubMed ID: 16688941
    [No Abstract]   [Full Text] [Related]  

  • 58. Congenital factor XII deficiency and lupus anticoagulant.
    Endo Y
    Intern Med; 1994 Mar; 33(3):188. PubMed ID: 8061401
    [No Abstract]   [Full Text] [Related]  

  • 59. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW; Henley A; Greenwood CK; Rangarajan S
    Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.